南京沃博生物科技有限公司 服务热线 15195831611
产品展厅product
TargetMol.T1902.BAY 11-7082
  • 品牌:TargetMol
  • 型号:5 mg
  • 货号:T1902
  • cas:19542-67-7
  • 价格: ¥455/瓶
  • 发布日期: 2023-05-08
  • 更新日期: 2024-08-30
产品详请
产地
品牌 TargetMol
货号 T1902
用途
英文名称
包装规格 5 mg
纯度 %
CAS编号 19542-67-7
别名
分子式
是否进口
产品描述
BAY 11-7082, a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation. BAY 11-7082 inhibits ubiquitin-specific protease USP7 and USP21.
体内活性
在NCI-H1703细胞中, BAY 11-7082(8 μM)能够抑制细胞增殖。在HTLV-I感染的T细胞系中,Bay 11-7082(5 μM)能够抑制NF-κB的DNA结合,并下调抗凋亡基因Bcl-x(L)的表达。在选择性诱导HTLV-1感染的T细胞系中, Bay11-7082(5 μM)能够引起细胞凋亡。在小鼠海马切片中,BAY 11-7082(100 μM)抑制NMDA诱导的NF-κB结合的增加,同时阻止NMDA引起的p65核转位。在骨骼肌中,BAY 11-7082(50-100 μM)显着抑制NF-κBp65 DNA结合活性。
激酶实验
UBE1 (0.17 μM) in 22.5 μL of 20 mM Hepes, pH 7.5, containing 10 μM ubiquitin is incubated for 45 min at 21°C with 1 μL of DMSO or 1 μL of BAY 11-7082 in DMSO. A 2.5 μL solution of 10 mM magnesium acetate and 0.2 mM ATP is added, incubated for 10 min at 30°C, and the reactions are terminated by the addition of 2.5 μL of 10% (w/v) SDS and heating for 6 min at 75°C. The samples are subjected to SDS/PAGE in the absence of any thiol. The gels are stained for 1 h with Coomassie Instant Blue and destained by washing with water. The loading of ubiquitin to E2 conjugating enzymes is carried out in an identical manner, except that UBE1 (0.17 μM) is mixed with Ubc13 (2.4 μM) or UbcH7 (2.9 μM) prior to incubation with BAY 11-7082[3].
细胞实验
Cells are transfected with siRNA in 96-well microtiter plates and then cultured for 72 hours in complete NSCLC medium, treated with BAY 11-7082 for 12 hours. Cells are incubated with [3H]thymidine for 3 hours. The cells are collected on filters using an automatic cell harvester and radioactivity on the filters is measured by β-scintillation counting.(Only for Reference)
Cas No.
19542-67-7
分子式
C10H9NO2S
分子量
207.25
别名
BAY 11-7821;BAY 11-7082
参考文献
[1]Gao J, Wang Y, Zhang W, et al. C20orf27 Promotes Cell Growth and Proliferation of Colorectal Cancer via the TGFβR-TAK1-NF?B Pathway[J]. Cancers. 2020, 12(2): 336. [2]Goffi F, et al. Neurosci Lett, 2005, 377(3), 147-151. [3]Gastonguay A, et al. Cancer Biol Ther, 2012, 13(8), 647-656. [4]Miwatashi S, et al. J Med Chem, 2005, 48(19), 5966-5979. [5]Mori N, et al. Blood, 2002, 100(5), 1828-1834. [6]Melisi D, et al. Expert Opin Ther Targets, 2007, 11(2), 133-144. [7]Yu Y, Li Z, Guo R, et al. Ononin, sec-O-β-D-glucosylhamaudol and astragaloside I: antiviral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary[J]. Pharmacological Research. 2019 May 11;145:104248. [8]Jun Jacob Hu, et al. Identification of pyroptosis inhibitors that target a reactive cysteine in gasdermin D. The Preprint Server For Biology, 2018,Jul. 10. [9]Shen S C, He F, Cheng C, et al. Uric acid aggravates myocardial ischemia–reperfusion injury via ROS/NLRP3 pyroptosis pathway[J]. Biomedicine & Pharmacotherapy . 2020, 133: 110990.
引用文献
[1]Chen J, Liu G, Wang X, et al. Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling. Cell Stem Cell. 2022 [2]Chen H, He A, Li H, et al. TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis. Cell Death & Disease. 2021, 12(10): 1-1 [3]Gao J, Wang Y, Zhang W, et al. C20orf27 Promotes Cell Growth and Proliferation of Colorectal Cancer via the TGFβR-TAK1-NF?B Pathway. Cancers. 2020, 12(2): 336 [4]Du T, Yan Z, Zhu S, et al. QKI deficiency leads to osteoporosis by promoting RANKL-inducedosteoclastogenesis and disrupting bone metabolism. Cell Death and Disease. 2020 [5]Du T, Yan Z, Zhu S, et al. QKI deficiency leads to osteoporosis by promoting RANKL-inducedosteoclastogenesis and disrupting bone metabolism. Cell Death and Disease. 2020 [6]Yu Y, Li Z, Guo R, et al. Ononin, sec-O-β-D-glucosylhamaudol and astragaloside I: antiviral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary. Pharmacological Research. 2019 May 11;145:104248 [7]Shen S C, He F, Cheng C, et al. Uric acid aggravates myocardial ischemia–reperfusion injury via ROS/NLRP3 pyroptosis pathway. Biomedicine & Pharmacotherapy. 2020, 133: 110990.
储存和溶解度
Ethanol:5.2 mg/mL (25 mM)
DMSO:20.7 mg/mL (100 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years